BioNTech: From pandemic hero to problem case:
The Mainz-based company is closing locations and cutting thousands of jobs. The pandemic hero has become a problem ...
telepolis.de/article/BioNTech-Vom-Pandemie-Helden-zum-Problemfall-11298720.html
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
Similar to This
Previous
Barron's Nov 13
Paid articlePaywall BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.: BioNTech has multiple catalysts that could generate a rally of 35% for the stock.
barrons.com/articles/buy-biontech-stock-price-pick-a64ac494
DAX Forecast: Lower - | US Midterms, Bayer, Lufthansa, FMC, BioNTech, AMD, Apple, Palantir in Focus
deraktionaer.de/artikel/indizes/dax-prognose-tiefer-us-midterms-bayer-lufthansa-fmc-biontech-amd-apple-palantir-im-fokus-20431435.html
BioNTech with figures: Forecasts beaten - | the details: BioNTech exceeds expectations in Q3 2026 with adjusted earnings of €1.76 per share ...
deraktionaer.de/artikel/pharma-biotech/biontech-mit-zahlen-prognosen-geschlagen-die-details-20432098.html
BioNTech closes sites - | New focus on tumor therapies: The Mainz-based company is closing three sites in Germany for which it has not found a buyer ...
nzz.ch/wirtschaft/vom-impfstoff-superstar-zum-aergernis-die-schwierige-suche-nach-der-zukunft-von-biontech-ld.10025914
No buyers found: Three German BioNTech sites will be closed: BioNTech earned billions during the Corona pandemic - | that's over now. The company has to cut ...
sueddeutsche.de/wirtschaft/biontech-standorte-werden-geschlossen-li.3555184
BioNTech on a restart course: Radical cut with an uncertain outcome: BioNTech has apparently already held confidential talks with interested parties about the ...
boerse-online.de/nachrichten/aktien/biontech-auf-neustart-kurs-radikaler-schnitt-mit-ungewissem-ausgang-20404154.html
Paid articlePaywall BioNTech: Tight race for new "super" cancer drug: Cancer patients, doctors, and the stock market are watching a new class of tumor drugs with bated breath ...
echo-online.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-kopf-an-kopf-rennen-um-super-krebsmedikament-5732517
OpinionCommentary: BioNTech founders Türeci and Şahin remain heroes: Özlem Türeci and Uğur Şahin are stepping down from biotech leadership to fight cancer with their ...
augsburger-allgemeine.de/wirtschaft/die-biontech-gruender-tuereci-und-sahin-bleiben-helden-114307503
BioNTech closes almost all of its German locations: In free fall: BioNTech earned billions during the pandemic with its Covid vaccine, Composition ...
freitag.de/autoren/thomas-trares/biontech-schliesst-fast-alle-deutschen-standorte-im-freien-fall
Bayer sues BioNTech and Pfizer over coronavirus vaccines: Did the manufacturers copy an old technology from Bayer subsidiary Monsanto? Bayer is now suing for ...
faz.net/aktuell/wirtschaft/unternehmen/bayer-verklagt-biontech-und-pfizer-wegen-corona-impfstoffen-accg-200415035.html
Paid articlePaywall Victory over the Corona pandemic: BioNTech gave the world hope five years ago: Corona cost millions of lives in the pandemic year of 2020. On December 2nd ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/sieg-ueber-corona-biontech-gab-welt-vor-fuenf-jahren-hoffnung-5211328
Moderna CEO: "The past two years haven't been fun": The biotechnology company sees itself back on track after a difficult period. CEO Stéphane Bancel reveals ...
faz.net/aktuell/wirtschaft/unternehmen/moderna-chef-die-vergangenen-zwei-jahre-waren-nicht-lustig-110791855.html
Corona vaccine partner Pfizer sells all BioNTech shares - | what's going on?: During the Corona pandemic, it was a brilliant vaccine partnership ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/partner-pfizer-stoesst-alle-biontech-aktien-ab-was-ist-los-5158281
Paid articlePaywall BioNTech launches major video campaign for at-risk groups regarding COVID-19 vaccination
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-faehrt-grosse-video-kampagne-zu-corona-impfung-5111619
Paid articlePaywall Biontech boss turns 60 - | the boy who wants to beat cancer: The "Lightspeed Project" of the first coronavirus vaccine catapults Ugur Sahin to the medical ...
mittelhessen.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-chef-wird-60-der-junge-der-krebs-besiegen-will-4993255
Paid articlePaywall Biontech in Mainz: On the way to the new "super" drug: Just like the coronavirus vaccine, a new type of Biontech cancer drug is now set to become a ...
op-marburg.de/lokales/marburg-biedenkopf/marburg/biontech-in-mainz-auf-dem-weg-zum-neuen-super-medikament-VISGHQEMQRHW7DLIWFC4VNYEUU.html
Pharma industry: Biontech halves loss - cancer strategy picks up speed: Biontech more than doubled its turnover in the second quarter. The company plans to spend ...
handelsblatt.com/unternehmen/industrie/pharmaindustrie-biontech-halbiert-verlust-krebsstrategie-nimmt-fahrt-auf/100146054.html
Key FactsBiontech Boosts Growth with Cancer Strategy and Deals
Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: handelsblatt.com
Summary created with AI assistance · Source: handelsblatt.com
- Biontech doubled its revenue to €260.8 million in Q2 and reduced its net loss to €386.6 million.
- The company is refocusing on oncology, strengthened by a partnership with Bristol Myers Squibb and the planned acquisition of Curevac.
- Over 20 studies involving BNT327 across various tumors are underway, with a pivotal breast cancer phase-3 study starting this year.
- Revenue is forecasted to decline in 2025 while R&D spending is expected to increase to as much as €2.8 billion.
We continue to invest significantly in the implementation of our strategy, and our operational and financial measures are showing initial tangible results.— CFO Ramón Zapata discusses Biontech's progress in cancer research.
Paid articlePaywall Biontech: Another high award for Sahin and Türeci: The award they received is a prestigious, but not a medical, honor. For this reason, the work of the two ...
allgemeine-zeitung.de/wirtschaft/wirtschaft-hessen-und-rheinland-pfalz/biontech-weitere-hohe-auszeichnung-fuer-sahin-und-tuereci-4703531
Biontech advances cancer therapies: Following the success of its coronavirus vaccines, the Mainz-based mRNA pioneer is now investing a lot of money in the ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-treibt-krebstherapien-voran-110457280.html
Next